These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10926357)

  • 1. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry.
    Maurer HH; Bickeboeller-Friedrich J
    J Anal Toxicol; 2000; 24(5):340-7. PubMed ID: 10926357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
    Salgado-Petinal C; Lamas JP; Garcia-Jares C; Llompart M; Cela R
    Anal Bioanal Chem; 2005 Jul; 382(6):1351-9. PubMed ID: 15986209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Tauvel FX; Kraemer T
    J Anal Toxicol; 2001; 25(4):237-44. PubMed ID: 11386636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study.
    Berzas Nevado JJ; Villaseñor Llerena MJ; Guiberteau Cabanillas C; Rodríguez Robledo V
    J Chromatogr A; 2006 Aug; 1123(1):130-3. PubMed ID: 16814307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Arlt JW
    J Anal Toxicol; 1999; 23(2):73-80. PubMed ID: 10192408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
    Eap CB; Bouchoux G; Amey M; Cochard N; Savary L; Baumann P
    J Chromatogr Sci; 1998 Jul; 36(7):365-71. PubMed ID: 9679303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation.
    Beyer J; Peters FT; Maurer HH
    Ther Drug Monit; 2005 Apr; 27(2):151-7. PubMed ID: 15795644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes.
    Bickeboeller-Friedrich J; Maurer HH
    Ther Drug Monit; 2001 Feb; 23(1):61-70. PubMed ID: 11206046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of 4-hydroxycoumarin anticoagulants and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Arlt JW
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):181-95. PubMed ID: 9766858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
    Eap CB; Baumann P
    J Chromatogr B Biomed Appl; 1996 Nov; 686(1):51-63. PubMed ID: 8953192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.
    Beyer J; Bierl A; Peters FT; Maurer HH
    Ther Drug Monit; 2005 Aug; 27(4):509-20. PubMed ID: 16044110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum.
    Tournel G; Houdret N; Hédouin V; Deveau M; Gosset D; Lhermitte M
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(2):147-58. PubMed ID: 11587344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
    Lucca A; Gentilini G; Lopez-Silva S; Soldarini A
    Ther Drug Monit; 2000 Jun; 22(3):271-6. PubMed ID: 10850393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of selective serotonin reuptake inhibitors in plasma and urine by micellar liquid chromatography coupled to fluorescence detection.
    Agrawal N; Esteve-Romero J; Bose D; Dubey NP; Peris-Vicente J; Carda-Broch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():142-9. PubMed ID: 25023211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and AT II receptor antagonists.
    Maurer HH; Kraemer T; Arlt JW
    Ther Drug Monit; 1998 Dec; 20(6):706-13. PubMed ID: 9853992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U; Gram LF; Vistisen K; Loft S; Poulsen HE; Brøsen K
    Eur J Clin Pharmacol; 1996; 51(1):73-8. PubMed ID: 8880055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatography-mass spectrometry detection of a norfluoxetine artifact in hydrolyzed urine samples may falsely indicate tranylcypromine ingestion.
    Schwaninger AE; Meyer MR; Maurer HH
    J Anal Toxicol; 2010; 34(1):45-8. PubMed ID: 20109302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.